STBX

SkinBiotherapeutics Plc

INTERVIEW: SkinBioTherapeutics PLC Increased Attention

SkinBioTherapeutics PLC (LON:SBTX) CEO Dr. Catherine O’Neill talks to DirectorsTalk about passing 3rd party cellular toxicity tests. Catherine explains what was involved and what this means for the company, key